Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2...
Redsense Medical AB reported revenue of 24.02 million SEK for fiscal year 2025, down 14.7% from fiscal year 2024, and net income of -7.17 million SEK.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.